Cardiotoxicity of Carfilzomib in Two Japanese Patients with Relapsed Multiple Myeloma

Although multiple myeloma (MM) had been an incurable hematological malignancy with a poor prognosis, recent advances in novel anti-neoplastic agents, including carfilzomib (a proteasome inhibitor), have improved the prognosis. We herein report two cases of congestive heart failure in patients treate...

Descripción completa

Detalles Bibliográficos
Autores principales: Ikoma, Takenori, Saotome, Masao, Sano, Makoto, Suwa, Kenichiro, Naruse, Yoshihisa, Ohtani, Hayato, Urushida, Tsuyoshi, Nagata, Yasuyuki, Ono, Takaaki, Maekawa, Yuichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599935/
https://www.ncbi.nlm.nih.gov/pubmed/30713316
http://dx.doi.org/10.2169/internalmedicine.2194-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599935/
https://www.ncbi.nlm.nih.gov/pubmed/30713316
http://dx.doi.org/10.2169/internalmedicine.2194-18

Ejemplares similares